Azitra, Inc.
AZTR
Rank in Stocks
#31033
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing... Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder. ATR-04: Another modified S. epidermidis strain, designed to alleviate the papulopustular rash commonly experienced by cancer patients undergoing epidermal growth factor receptor inhibitor therapy. ATR-01: An engineered recombinant human filaggrin protein developed for the treatment of ichthyosis vulgaris, another dermatological ailment. Founded in 2014, Azitra, Inc. operates from its headquarters in Branford, Connecticut.
Share Price
$0.644
Last synced: 2026-11-09
Market Cap
$3.90M
Change (1 day)
-12.08%
Change (1 year)
62.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Azitra, Inc. (AZTR)
Category
Healthcare
Operating Margin for Azitra, Inc. (AZTR)
Operating Margin as of November 2026 TTM: 0.00%
According to Azitra, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Azitra, Inc. from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -146,468.53% | 13,385.86% |
| 2023 | -1,086.09% | -67.37% |
| 2022 | -3,328.73% | -60.29% |
| 2021 | -8,383.14% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Azitra, Inc.'s operating margin
What was Azitra, Inc.'s operating margin in 2025?
In 2025, Azitra, Inc.'s operating margin was 0.00%, compared with -146,468.53% in 2024.
How has Azitra, Inc.'s operating margin changed since 2021?
From 2021 to 2025, Azitra, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-146,468.53%).
How does Azitra, Inc.'s operating margin compare with similar companies?
Azitra, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.